Skip to main content

Table 3 Psychiatric status

From: Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines

Group of patients Treated with haloperidol
(n = 30)
Treated with olanzapine
(n = 30)
Visit number V1 V2 V3 V1 V2 V3
PANSS Total scores (mean ± sd) 91.4 ± 13.6 79.6 ± 14.7 73.5 ± 17.3 87.4 ± 18.9 72.1 ± 19.0 63.8 ± 19.3
CGI-S scores (mean ± sd) 5.4 ± 0.8 4.6 ± 0.9 4.04 ± 1.04 5.1 ± 0.9 4.14 ± 1.1 3.5 ± 1.1
CGI-I scores (mean ± sd) 3.0 ± 0.7 2.8 ± 0.9 2.89 ± 0.9 2.8 ± 1.1
SAS scores (mean ± sd) 0.17 ± 0.54 4.8 ± 4.14 6.6 ± 4.37 0.07 ± 0.26 0.96 ± 1.86 0.85 ± 1.5
ESRS scores (mean ± sd) 0.4 ± 1.42 18.1 ± 14.9 22.6 ± 14.9 0.45 ± 2.4 3.5 ± 5.3 3.2 ± 5.2
  1. sd – standard deviation
  2. PANSS – Positive and Negative Syndrome Scale for Schizophrenia
  3. CGI-S – Clinical Global Impression of Severity
  4. CGI-I – Clinical Global Impression of Improvement
  5. SAS – Simpson-Angus Scale for Extrapyramidal Symptoms
  6. ESRS – Extrapyramidal Rating Scale